Use

Therapeutic drug monitoring of everolimus (a mammalian target of rapamycin inhibitor) is utilized to optimize dosing to achieve therapeutic efficacy while minimizing toxicity. Whole blood trough levels are typically measured to guide dosage adjustments in transplant recipients, particularly renal and hepatic transplant patients, where maintaining concentrations within a target range is essential for preventing graft rejection and reducing adverse effects.